LGI Homes Q3 2026 earnings reveal leadership test in downturn

By: John McManus

On: November 4, 2026, 3:30 pm EST

URL has been copied successfully!

SG&A ratio improved 180 bps year over year, while backlog fell 47.5% and guidance narrowed to 4,600 to 4,800 closings

Share this story:

This post was originally published on here.

Boehringer Ingelheim biopharmaceutical manufacturing facility in Shanghai

Previous Post:Boehringer and Sino Biopharma Sign Cancer Research Deal With $358 Million in Initial Payments

Next Post:Medicare spends more on hospices owned by private equity firms, study finds